Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -85,469 | -42,925 | N/A | N/A | N/A |
| Depreciation Amortization | 14,141 | 3,062 | N/A | N/A | N/A |
| Income taxes - deferred | -2,113 | -11,320 | N/A | N/A | N/A |
| Accounts receivable | 3,249 | -511 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 7,219 | 800 | N/A | N/A | N/A |
| Other Working Capital | 8,105 | -1,697 | N/A | N/A | N/A |
| Other Operating Activity | 44,251 | 31,915 | 0 | 0 | 0 |
| Operating Cash Flow | $-10,617 | $-20,676 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -54,597 | 6,067 | N/A | N/A | N/A |
| PPE Investments | 11,514 | -22 | N/A | N/A | N/A |
| Investing Cash Flow | $-43,083 | $6,045 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 19,333 | N/A | N/A | N/A |
| Debt Repayment | -34,908 | -552 | N/A | N/A | N/A |
| Common Stock Issued | 132,260 | 400 | N/A | N/A | N/A |
| Other Financing Activity | -1,357 | -907 | 0 | 0 | 0 |
| Financing Cash Flow | $95,995 | $18,274 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | -9,171 | 251 | N/A | N/A | N/A |
| Beginning Cash Position | 6,636 | 2,742 | N/A | N/A | N/A |
| End Cash Position | 39,760 | 6,636 | N/A | N/A | N/A |
| Net Cash Flow | $33,124 | $3,894 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,617 | -20,676 | N/A | N/A | N/A |
| Capital Expenditure | -1,728 | -1,029 | N/A | N/A | N/A |
| Free Cash Flow | -12,345 | -21,705 | 0 | 0 | 0 |